Ali

47%
Flag icon
Two of the promising disease targets for ex vivo CRISPR therapies are sickle cell disease and beta-thalassemia.
A Crack In Creation: A Nobel Prize Winner's Insight into the Future of Genetic Engineering
Rate this book
Clear rating
Open Preview